Biotech Values

[quantumdot]

In the study of 167 people, patients who received ablation treatment showed a 75 percent reduction in recurrence of atrial fibrillation, compared with 21 percent for patients treated with anti-arrhythmic drugs.

Exceptional results, even with the small trial size. J&J seems to consistently produce winners.